Cleared Special

K242693 - DEKA Infusion System, DEKA Administration Set (FDA 510(k) Clearance)

Oct 2024
Decision
28d
Days
Class 2
Risk

K242693 is an FDA 510(k) clearance for the DEKA Infusion System, DEKA Administration Set. This device is classified as a Controller, Infusion, Intravascular, Electronic (Class II - Special Controls, product code LDR).

Submitted by Deka Research and Development Corporation (Manchester, US). The FDA issued a Cleared decision on October 7, 2024, 28 days after receiving the submission on September 9, 2024.

This device falls under the General Hospital FDA review panel. Regulated under 21 CFR 880.5725.

Submission Details

510(k) Number K242693 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 09, 2024
Decision Date October 07, 2024
Days to Decision 28 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Summary PDF

Device Classification

Product Code LDR - Controller, Infusion, Intravascular, Electronic
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.5725